Contoura With Phorcides Compared to Wavefront Optimized LASIK
Recruiting now · Not applicable
Conditions studied: Myopia, Astigmatism
In brief
Comparing post-operative visual acuity and patient reported satisfaction between Contoura with Phorcides and WaveLight Wavefront Optimized.
Key facts
- Study ID
- NCT05486546
- Run by
- Daniel Terveen
- People needed
- 120
- Starts
- 2022-08-15
- Expected to finish
- 2023-12-01
- Last updated by the study team
- 2023-04-26
Who can join
Age: 21 and older, up to 38. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients at least age 21 years of age undergoing LASIK eye surgery
- Willing and able to comprehend informed consent and complete 1 month post-op visit
- Potential postoperative BCDVA of 20/20 or better in each eye based on Investigator's medical opinion
- Candidates for Contoura with Phorcides (Myopic, astigmatism <3.0D)
- Both eyes targeted for plano
- Pre-operative total corneal Pachymetry 490um or above
- Stable refractive error <0.50D change in preceding year
- Good general and ocular health
- Pre-operative exam completed within three months of surgery
- SCL discontinued 3 days prior to pre-op exam and the procedure
- Pachymetry above 490 with residual greater than 270um
- Candidates who, as determined by the investigator, can safely undergo LASIK
You may not qualify if…
- Patients under 21 years of age
- Concomitant ocular condition which would limit the BCVA at the discretion of the surgeon
- Patients with usual relative and absolute contraindications for LASIK surgery (Patients with severe dry eye, recurrent corneal erosion, uncontrolled Glaucoma, collagen vascular disorders, keratoconus or signs of keratoconus, uncontrolled Diabetes, Herpes)
- Pachymetry below 490
- Autoimmune or immunodeficiency diseases
- Pregnant or nursing women
- Patients with signs of inability to understand consent for study and procedure planned
- Patients with history of previous ocular surgery
- Patients with strabismus or amblyopia
- Patients that have a BCDVA of 20/25 or worse in either eye
Where it is running
- Vance Thompson Vison — Bozeman, Montana, United States (enrolling)
- Vance Thompson Vision — Omaha, Nebraska, United States (enrolling)
- Vance Thompson Vision — Fargo, North Dakota, United States (enrolling)
- Vance Thompson Vision — Sioux Falls, South Dakota, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.